95 related articles for article (PubMed ID: 7992085)
21. Multiple actions of somatostatin in neoplastic disease.
Reubi JC; Laissue JA
Trends Pharmacol Sci; 1995 Mar; 16(3):110-5. PubMed ID: 7792931
[TBL] [Abstract][Full Text] [Related]
22. Conclusions: the future role of somatostatin analogs.
Lamberts SW
J Endocrinol Invest; 2003; 26(8 Suppl):134-5. PubMed ID: 15233230
[No Abstract] [Full Text] [Related]
23. Potential indications for somatostatin analogs in Cushing's syndrome.
Arnaldi G; Polenta B; Cardinaletti M; Boscaro M
J Endocrinol Invest; 2005; 28(11 Suppl International):106-10. PubMed ID: 16625858
[TBL] [Abstract][Full Text] [Related]
24. [Somatostatinergic control of Kaposi's sarcoma growth through the inhibition of angiogenesis].
Corsaro A; Thellung S; Villa V; Arena S; Noonan D; Albini A; Schettini G; Florio T
Minerva Endocrinol; 2001 Dec; 26(4):273-6. PubMed ID: 11782715
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of therapeutic effects of targeted cytotoxic analogs of somatostatin and bombesin on human gastric carcinomas.
Szepeshazi K; Schally AV; Nagy A; Wagner BW; Bajo AM; Halmos G
Cancer; 2003 Oct; 98(7):1401-10. PubMed ID: 14508826
[TBL] [Abstract][Full Text] [Related]
26. International Symposium on Somatostatin Analogs: Basic Update and Clinical Perspectives. Venice, Italy, October 24-25, 1997. Abstracts.
J Endocrinol Invest; 1997; 20(7 Suppl):1-106. PubMed ID: 9484527
[No Abstract] [Full Text] [Related]
27. Physiology of somatostatin receptors.
Guillermet-Guibert J; Lahlou H; Cordelier P; Bousquet C; Pyronnet S; Susini C
J Endocrinol Invest; 2005; 28(11 Suppl International):5-9. PubMed ID: 16625838
[TBL] [Abstract][Full Text] [Related]
28. Hypothalamic hormones and cancer.
Schally AV; Comaru-Schally AM; Nagy A; Kovacs M; Szepeshazi K; Plonowski A; Varga JL; Halmos G
Front Neuroendocrinol; 2001 Oct; 22(4):248-91. PubMed ID: 11587553
[TBL] [Abstract][Full Text] [Related]
29. In vitro testing of new somatostatin analogs on pituitary tumor cells.
Zatelli MC; Ambrosio MR; Bondanelli M; degli Uberti EC
Mol Cell Endocrinol; 2008 May; 286(1-2):187-91. PubMed ID: 18243520
[TBL] [Abstract][Full Text] [Related]
30. [New developments in somatostatin analogs and their receptors].
Jaquet P
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 3):2S3-4. PubMed ID: 12037500
[No Abstract] [Full Text] [Related]
31. Potential role of somatostatin analogues in the treatment of cancer.
Lamberts SW; Koper JW; Reubi JC
Eur J Clin Invest; 1987 Aug; 17(4):281-7. PubMed ID: 2889601
[No Abstract] [Full Text] [Related]
32. Oncological applications of somatostatin analogues.
Schally AV
Cancer Res; 1988 Dec; 48(24 Pt 1):6977-85. PubMed ID: 2903792
[No Abstract] [Full Text] [Related]
33. Somatostatin analogs and receptors. Diagnostic and therapeutic applications.
Hofland LJ; Lamberts SW
Cancer Treat Res; 1997; 89():365-82. PubMed ID: 9204201
[No Abstract] [Full Text] [Related]
34. Somatostatin and somatostatin analogues in oncology.
Parmar H; Bogden A; Mollard M; de Rougé B; Phillips RH; Lightman SL
Cancer Treat Rev; 1989 Jun; 16(2):95-115. PubMed ID: 2569933
[No Abstract] [Full Text] [Related]
35. [Biological activities of somatostatin analogs (author's transl)].
Kokubu T; Sawano S
Horumon To Rinsho; 1979 May; 27(5):473-82. PubMed ID: 378472
[No Abstract] [Full Text] [Related]
36. Use of somatostatin analogues in terminal cancer patients.
Fainsinger RL; Pisani A; Bruera E
J Palliat Care; 1993; 9(1):56-7. PubMed ID: 7684079
[No Abstract] [Full Text] [Related]
37. Somatostatin analogues: mechanisms of action.
Parmar H; Phillips RH; Lightman SL
Recent Results Cancer Res; 1993; 129():1-24. PubMed ID: 8102487
[No Abstract] [Full Text] [Related]
38. [Somatostatin analogs. Proceedings of a conference. Napoli, Italy, 16-17, 2001].
Minerva Endocrinol; 2001 Sep; 26(3):89-195. PubMed ID: 11753229
[No Abstract] [Full Text] [Related]
39. Somatostatin analogs: status of the art and perspectives in the treatment of endocrine and non endocrine diseases. Proceedings of a conference. May 30-31, 2003. Naples, Italy.
J Endocrinol Invest; 2003; 26(8 Suppl):1-135. PubMed ID: 15307251
[No Abstract] [Full Text] [Related]
40. [New antiproliferative agents].
Breau JL
Pathol Biol (Paris); 1990 Oct; 38(8):788-90. PubMed ID: 1980358
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
